Studies in rodents and humans (Chaldakov et al., 2004; Motamedi et al., 2017) have shown that low levels of circulating BDNF are associated with metabolic dysfunctions such as obesity, metabolic syndrome and related disorders (e.g., diabetes, cardiovascular disease). Here, BDNF is linked to obesity due to melanocortin 4 receptor deficiency.